Publications by authors named "Kenneth Lebioda"

Claim this Profile
A
Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment.
Dean Gilham, Sylwia Wasiak, Brooke D Rakai, Li Fu, Laura M Tsujikawa, Kenneth Lebioda

Biomedicines· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial.
Jeffrey Cummings, Gregory G Schwartz, Stephen J Nicholls, Aziz Khan, Chris Halliday, Kenneth Lebioda

J Alzheimers Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Apabetalone on Cardiovascular Events in Diabetes, CKD, and Recent Acute Coronary Syndrome: Results from the BETonMACE Randomized Controlled Trial.
Kamyar Kalantar-Zadeh, Gregory G Schwartz, Stephen J Nicholls, Kevin A Buhr, Henry N Ginsberg, Kenneth Lebioda

Clin J Am Soc Nephrol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apabetalone lowers serum alkaline phosphatase and improves cardiovascular risk in patients with cardiovascular disease.
Mathias Haarhaus, Kausik K Ray, Stephen J Nicholls, Gregory G Schwartz, Ewelina Kulikowski, Kenneth Lebioda

Atherosclerosis· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apabetalone Mediated Epigenetic Modulation is Associated with Favorable Kidney Function and Alkaline Phosphatase Profile in Patients with Chronic Kidney Disease.
Ewelina Kulikowski, Christopher Halliday, Jan Johansson, Mike Sweeney, Kenneth Lebioda

Kidney Blood Press Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis